103 related articles for article (PubMed ID: 20399571)
1. Immunohistochemical FHIT expression still exists in early lesions of basal cell carcinoma.
Kiyici H; Bilezikçi B; Ozen O; Demirhan B
Pathol Res Pract; 2010 Jul; 206(7):445-9. PubMed ID: 20399571
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of fragile histidine triad in oral cancer and precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):584-6. PubMed ID: 15897145
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of Fhit expression in development of colorectal carcinoma of various macroscopic types.
Kuwai T; Tanaka S; Kaio E; Hiyama T; Ito M; Kitadai Y; Sumii M; Yoshihara M; Haruma K; Chayama K
Int J Mol Med; 2003 Oct; 12(4):437-42. PubMed ID: 12964015
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.
Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG
Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
[TBL] [Abstract][Full Text] [Related]
7. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y
Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444
[TBL] [Abstract][Full Text] [Related]
8. Concordant loss of fragile gene expression early in breast cancer development.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.
Mori M; Mimori K; Shiraishi T; Alder H; Inoue H; Tanaka Y; Sugimachi K; Huebner K; Croce CM
Cancer Res; 2000 Mar; 60(5):1177-82. PubMed ID: 10728669
[TBL] [Abstract][Full Text] [Related]
10. [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):812-4. PubMed ID: 16027075
[TBL] [Abstract][Full Text] [Related]
11. [Reduction of FHIT gene expression in primary lung cancer: relationship with the proliferation and apoptosis of tumor cell].
Wang Y; Zhou Q; Zhang S; Yang H; Cheng N; Li L; Wu Z; Liu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):178-82. PubMed ID: 11402444
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma].
Yin DT; Lu XB; Dong MM; Qiu XG; Wang QZ
Ai Zheng; 2004 Nov; 23(11):1338-41. PubMed ID: 15522186
[TBL] [Abstract][Full Text] [Related]
13. Expression of FHIT in esophageal epithelium and carcinoma: reference to drinking, smoking and multicentric carcinogenesis.
Morita M; Oyama T; Nakata S; Ono K; Sugaya M; Uramoto H; Yoshimatsu T; Hanagiri T; Sugio K; Yasumoto K
Anticancer Res; 2006; 26(3B):2243-8. PubMed ID: 16821595
[TBL] [Abstract][Full Text] [Related]
14. Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer.
Paradiso A; Ranieri G; Stea B; Zito A; Zehbe I; Tommasino M; Grammatica L; De Lena M
Int J Oncol; 2004 Feb; 24(2):249-55. PubMed ID: 14719099
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
Mateoiu C; Pirici A; Bogdan F
Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
[TBL] [Abstract][Full Text] [Related]
16. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P
Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between the expression of fragile histidine (FHIT) and the development of vulvar carcinoma].
Chu YX; Zheng A; Xi MR; Zhang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):218-20. PubMed ID: 16608079
[TBL] [Abstract][Full Text] [Related]
18. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
[TBL] [Abstract][Full Text] [Related]
19. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
[TBL] [Abstract][Full Text] [Related]
20. [Fragile histidine triad expression in rhabdomyosarcoma].
Wang SL; Yang GH; Bu H; Guo LX; Zhou Q; Zhang HY; Ye L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):176-8. PubMed ID: 15071908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
